Can Small Molecule Inhibitors of Glutaminyl Cyclase Be Used as a Therapeutic for Alzheimer's Disease?

Future Medicinal Chemistry- United Kingdom

doi 10.4155/fmc-2017-0190

Full Text

Abstract

Available in

Categories

Molecular Medicine

Date

November 1, 2017

Authors

Publisher

Future Science Ltd

Related search

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Can the Retina Be Used to Diagnose and Plot the Progression of Alzheimer's Disease?

Acta Ophthalmologica

English

Identification of a Mammalian Glutaminyl Cyclase Converting Glutaminyl Into Pyroglutamyl Peptides.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?

Neurotherapeutics

English

How Children Can Be Respected as 'Ends' Yet Still Be Used as Subjects in Non-Therapeutic Research.

Journal of Medical Ethics

English

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

English

EGFR Inhibitors, MHC Expression and Immune Responses : Can EGFR Inhibitors Be Used as Immune Response Modifiers?

English

Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimers Agents by Structure-Based Design

English

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology

Molecular Medicine

English